23andMe (ME)
搜索文档
23andMe (ME) - 2023 Q2 - Earnings Call Transcript
2022-11-08 11:32
23andMe Holding Co. (NASDAQ:ME) Q2 2023 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Wade Walke - Vice President-Investor Relations Anne Wojcicki - Chief Executive Officer & Co-Founder Joe Selsavage - Interim Chief Financial Officer & Accounting Officer Kenneth Hillan - Chief Therapeutics Officer Conference Call Participants Tiago Fauth - Credit Suisse Steven Mah - Cowen Operator Good day, and thank you for standing by. Welcome to the 23andMe's Fiscal Year 2023 Second Quarter Ea ...
23andMe (ME) - 2023 Q1 - Earnings Call Transcript
2022-08-09 09:41
23andMe Holding Co. (NASDAQ:ME) Q1 2023 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Wade Walke - Vice President, Investor Relations Anne Wojcicki - Chief Executive Officer & Co-Founder Steve Schoch - Chief Financial Officer Kenneth Hillan - Chief Therapeutics Officer Conference Call Participants Tiago Fauth - Credit Suisse David Lebowitz - Citi Operator Good morning, and welcome to 23andMe's Fiscal 2023 First Quarter Financial Results Conference Call. As a reminder this call is b ...
23andMe (ME) - 2022 Q4 - Earnings Call Transcript
2022-05-27 09:35
23andMe Holding Co. (NASDAQ:ME) Q4 2022 Earnings Conference Call May 26, 2022 4:30 PM ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Kenneth Hillan - Chief Therapeutics Officer Steve Schoch - Chief Financial Officer Conference Call Participants Tiago Fauth - Credit Suisse AG Daniel Grosslight - Citigroup Inc. Operator Good morning, and welcome to the 23andMe's Fiscal Year 2022 Fourth Quarter and Year-End Financial Results Conf ...
23andMe (ME) - 2022 Q3 - Earnings Call Transcript
2022-02-11 10:13
23andMe Holding Co. (NASDAQ:ME) Q3 2022 Earnings Conference Call February 10, 2022 4:30 PM ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder & Chief Executive Officer Steve Schoch - Chief Financial Officer Kenneth Hillan - Head of Therapeutics Conference Call Participants Tiago Fauth - Credit Suisse Daniel Grosslight - Citi Operator Good morning and welcome to 23andMe's Fiscal Year 2022 Third Quarter Financial Results Conference Call. As a reminder, this ca ...
23andMe (ME) - 2021 Q2 - Earnings Call Transcript
2021-11-11 09:24
23andMe Holding Co. (NASDAQ:ME) Q2 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Wade Walke - VP, IR Anne Wojcicki - Co-Founder, CEO, President & Director Steven Schoch - Chief Financial & Accounting Officer Kenneth Hillan - Head, Therapeutics Conference Call Participants Daniel Grosslight - Citigroup Operator Good day, ladies and gentlemen, and welcome to the 23andMe's Fiscal Year 2022 Second Quarter Earnings Call. [Operator Instructions]. As a reminder, this conference ca ...
23andMe (ME) - 2022 Q1 - Earnings Call Transcript
2021-08-14 04:36
23andMe Holding Co. (NASDAQ:ME) Q1 2022 Earnings Conference Call August 13, 2021 11:00 AM ET Company Participants Wade Walke ??? Vice President-Investor Relations Anne Wojcicki ??? Co-Founder and Chief Executive Officer Steve Schoch ??? Chief Financial Officer Kenneth Hillan ??? Head-Therapeutics Conference Call Participants Daniel Grosslight ??? Citi Operator Good morning, and welcome to 23andMe???s Fiscal Year 2022 First Quarter Financial Results Conference Call. As a reminder, this call is being recorded ...